University of Virginia at AES 2026
Dec 4–8, 2026 Denver, CO ~6.2k attendees Website
University of Virginia brings 10 presentations to AES 2026 in Denver. Its program covers self-sustaining status epilepticus, metabolic targets for new seizure treatments such as beta-hydroxybutyrate, vascular risk in epilepsy, daily functioning in older adults and the national plan for epilepsy, plus an introduction to a federal clinical trials methodology course.
| Organization | AES 2026 Attendance |
|---|---|
University of Virginia Charlottesville, VA | |
Symposium Fri, Dec 4 8:30am–11:00am Workshop Fri, Dec 4 3:00pm–3:30pm Introduction to the NINDS Clinical Trials Methodology Course How a National Institute of Neurological Disorders and Stroke course trains early-career investigators to design clinical trials, and how to apply. Workshop Fri, Dec 4 3:00pm–3:30pm Professional Development | Introduction to the NINDS Clinical Trials Methodology Course How a National Institute of Neurological Disorders and Stroke course trains early-career investigators to design clinical trials, and how to apply. Workshop Sat, Dec 5 7:30am–5:00pm Workshop Sat, Dec 5 2:30pm–4:00pm Symposium Sun, Dec 6 8:45am–5:15pm Workshop Sun, Dec 6 10:30am–12:00pm Workshop Sun, Dec 6 10:30am–12:00pm Workshop Sun, Dec 6 10:30am–12:00pm |
Find decision makers at University of Virginia
Tell us what you sell and we’ll find the people at University of Virginia most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the American Epilepsy Society. Organization details are derived from AES’s published exhibitor list and online program, and each exhibitor’s own profile and website. Submit a correction